India Drug Makers Rely On Indian-American Scientists To Stay Current
This article was originally published in PharmAsia News
India drug makers are looking increasingly to Indian-American scientists in the U.S. to help them understand and negotiate stricter FDA rules governing imports.
You may also be interested in...
Stephen Hahn’s low visibility period as the newly installed FDA commissioner comes to an abrupt end. Trump offers generous praise amid COVID-19 response – but how quickly might that change to blame?
The latest drug development news and highlights from the Pink Sheet US FDA Performance Tracker.
Assessment work also isn’t slowing down, the new and generic drug office directors said in an interview, but approval data offers a note of concern.